Publications

Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors. Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C.. Invest New Drugs. 2017; : . doi:10.1007/s10637-017-0531-3 10.1007/s10637-017-0531-3.

Article
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A.. BJU Int. 2017; : . doi:10.1111/bju.14021 10.1111/bju.14021.

Article
Addictive behaviors and healthcare renunciation for economic reasons in a French population-based sample. Baggio, S; Dupuis, M; Richard, JB; Beck, F. International Journal of Drug Policy. 2017; : . doi:10.1016/j.drugpo.2017.07.004
    Article
    Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study). Fresneau, Brice; Hackshaw, A.; Hawkins, D. S.; Paulussen, M.; Anderson, J. R.; Judson, I.; Litière, S.; Dirksen, U.; Lewis, I.; van den Berg, H.; Gaspar, N.; Gelderblom, H.; Whelan, J.; Boddy, A. V.; Wheatley, K.; Pignon, J. P.; De Vathaire, F.; Le Deley, M. C.; Le Teuff, G.. Pediatric Blood & Cancer. 2017; : . doi:10.1002/pbc.26457
    Article
    Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013). Delannoy, Alexandra; Rudant, Jérémie; Chaignot, Christophe; Bolgert, Francis; Mikaeloff, Yann; Weill, Alain. Journal of the peripheral nervous system: JPNS. 2017; 51-58: p.51-58. doi:10.1111/jns.12202
      Article
      Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials. Block, Geoffrey A.; Bushinsky, David A.; Cunningham, John; Drüeke, Tilman B.; Ketteler, Markus; Kewalramani, Reshma; Martin, Kevin J.; Mix, T. Christian; Moe, Sharon M.; Patel, Uptal D.; Silver, Justin; Spiegel, David M.; Sterling, Lulu; Walsh, Liron; Chertow, Glenn M.. JAMA. 2017; 317: p.146-155. doi:10.1001/jama.2016.19456
      Article
      Nevi, Ambient Ultraviolet Radiation, and Thyroid Cancer Risk: A French Prospective Study. Mesrine, Sylvie; Kvaskoff, Marina; Bah, Thierno; Wald, Lucien; Clavel-Chapelon, Françoise; Boutron-Ruault, Marie-Christine. Epidemiology (Cambridge, Mass.). 2017; 28: p.694-702. doi:10.1097/EDE.0000000000000673
      Article
      Exposition solaire, compléments alimentaires en antioxydants et risque de cancers cutanés dans la cohorte de femmes E3N. Savoye, Isabelle; Boutron-Ruault, Marie-Christine; Kvaskoff, Marina. []: Université Paris-Saclay (ComUE); 2017.
      Thesis
      Association Between Planned Cesarean Delivery and Neonatal Mortality and Morbidity in Twin Pregnancies. Schmitz, T.; Prunet, C.; Azria, E.; Bohec, C.; Bongain, A.; Chabanier, P.; D'Ercole, C.; Deruelle, P.; De Tayrac, R.; Dreyfus, M.; Dupont, C.; Gondry, J.; Graesslin, O.; Kayem, G.; Langer, B.; Marpeau, L.; Morel, O.; Parant, O.; Perrotin, F.; Pierre, F.; Poulain, P.; Riethmuller, D.; Rozenberg, P.; Rudigoz, R. C.; Sagot, P.; Senat, M. V.; Sentilhes, L.; Vayssiere, C.; Venditelli, F.; Verspyck, E.; Winer, N.; Lecomte-Raclet, L.; Ancel, P. Y.; Goffinet, F.; Group, J. Umeaux MODe d'Accouchement Study; the Groupe de Recherche en Obstetrique et, Gynecologie. Obstet Gynecol. 2017; 129: p.986-995. doi:10.1097/AOG.0000000000002048
      Article
      Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial. Belin, L.; Kamal, M.; Mauborgne, C.; Plancher, C.; Mulot, F.; Delord, J. P.; Gonçalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Trédan, O.; Ricci, F.; Alt, M.; Loirat, D.; Sablin, M. P.; Paoletti, X.; Servois, V.; Le Tourneau, C.. Ann. Oncol.. 2017; 590-596: p.590-596. doi:10.1093/annonc/mdw666
      Article